Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C, Mainini F, Digifico E, Maeda A, Sironi M, Erreni M, Anselmo A, Ummarino A, Gandoy S, Expósito F, Redrado M, Serrano D, Calvo A, Martens M, Bravo S, Mantovani A, Allavena P, Andón FT.
Anfray C, et al. Among authors: allavena p.
J Immunother Cancer. 2021 Sep;9(9):e002408. doi: 10.1136/jitc-2021-002408.
J Immunother Cancer. 2021.
PMID: 34531246
Free PMC article.